J. Thomas Schuetz's Insider Trades & SAST Disclosures

J. Thomas Schuetz's most recent trade in Compass Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on May 27, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.11 per share. 27 May 2025 10,000 6,480,825 - 2.1 21,100 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 1,500,000 1,500,000 - - Stock Option (Right to Buy)
Compass Therapeutics Inc
Thomas J. Schuetz Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.50 per share. 08 Feb 2025 41,687 6,470,825 - 3.5 145,905 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. 09 Jan 2025 58,054 6,512,512 - 1.9 107,980 Common Stock
Compass Therapeutics Inc
J. Thomas Schuetz Director, PRESIDENT Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. 08 Feb 2024 44,782 6,570,566 - 1.5 64,934 Common Stock
Compass Therapeutics Inc
Schuetz Thomas J. Director, President of R&D Grant, award, or other acquisition of securities at price $ 1.93 per share. 09 Jan 2024 637,500 6,615,348 - 1.9 1,230,375 Common Stock
Compass Therapeutics Inc
J. Schuetz Thomas Director, President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2024 637,500 637,500 - - Stock Option (Right to Buy)
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.37 per share. 10 Mar 2023 10,000 6,021,873 - 3.4 33,700 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.98 per share. 27 Feb 2023 20,000 6,011,873 - 4.0 79,600 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.86 per share. 15 Feb 2023 20,000 5,991,873 - 3.9 77,200 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 700,000 700,000 - - Stock Option (Right to Buy)
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 500,000 5,971,873 - 0 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 4.05 per share. 31 Jan 2023 20,000 5,471,873 - 4.1 81,000 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 4.19 per share. 24 Jan 2023 20,000 5,451,873 - 4.2 83,800 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.32 per share. 28 Sep 2022 10,000 5,431,873 - 2.3 23,200 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.27 per share. 26 Sep 2022 15,000 5,421,873 - 2.3 34,050 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.03 per share. 07 Sep 2022 15,000 5,406,873 - 3.0 45,450 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.83 per share. 01 Sep 2022 15,000 5,391,873 - 2.8 42,450 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.05 per share. 17 Aug 2022 15,000 5,376,873 - 3.1 45,750 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.64 per share. 10 Aug 2022 15,000 5,361,873 - 2.6 39,600 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.58 per share. 01 Aug 2022 15,000 5,346,873 - 2.6 38,700 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.80 per share. 21 Jun 2022 20,000 5,331,873 - 2.8 56,000 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.34 per share. 16 Jun 2022 20,000 5,311,873 - 2.3 46,800 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.29 per share. 13 Jun 2022 30,000 5,291,873 - 2.3 68,700 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.83 per share. 06 Jun 2022 30,000 5,261,873 - 2.8 84,900 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.03 per share. 01 Jun 2022 20,000 5,231,873 - 3.0 60,600 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.04 per share. 26 May 2022 20,000 5,211,873 - 3.0 60,800 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.72 per share. 23 May 2022 18,355 5,191,873 - 2.7 49,926 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.47 per share. 17 May 2022 20,215 5,173,518 - 2.5 49,931 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 1.80 per share. 10 May 2022 27,836 5,153,303 - 1.8 50,105 Common Stock
Compass Therapeutics Inc
Thomas J. Schuetz Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 700,000 700,000 - - Stock Option (Right to Buy)
Compass Therapeutics Inc
Thomas J. Schuetz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Nov 2021 600,000 5,125,467 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades